Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium addition during inhalational induction in infants to reduce hypoxemia
2015-001668-21Phase 4Completed
- Sponsor
- Adolphe de Rothschild Foundation Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anoxemia comparing Rocuronium arm with Placebo arm (2 arms). Primary endpoint: Incidence of hypoxemia. Started Jul 2024; status: completed.
02
Drugs
rocuronium
03
Conditions
anoxemia
Beyond the preview
Go deeper on 2015-001668-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001668-21.